Global Coronary Stent Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 4420972
  • Report
  • Region: Global
  • 190 Pages
  • Occams Business Research and Consulting
1 of 4
The Global Coronary Stent Market is Expected to Grow at a CAGR of 7.10% During 2016-2023

FEATURED COMPANIES

  • Fortimedix B.V.
  • I.B.S. S.P.A
  • Medtronic Plc (U.S)
  • Stentys Sa (France)
  • MORE

Coronary stent market is the market of coronary stents which are used for opening the blocked artery during coronary heart procedures such as, in percutaneous coronary intervention (PCI). Coronary stents are helpful for reducing chest pain and helps in increasing survival rate of patients. The global coronary stent market is anticipated to grow at a CAGR of 7.10% for the forecast period 2016-2023. The growth drivers in the global coronary stent market are the increasing geriatric population, the rising incidence of coronary artery disease and the subsequent growth in the number of PCI procedures. According to national program from prevention and control diabetes, stroke and CVD, in India, it is estimated that by the end of 2020, cardio artery diseases could be one of the major factors that result in mortality. In contrary stent market, availability of alternative treatment methods such as Enhanced external counterpulsation (EECP) for coronary artery disease, stringent regulations for product approval and product failure and product recalls are market factors that are hindering market growth for forecast period 2016-2023.

The growing geriatric population worldwide has resulted in the increasing probability of prevalence of coronary heart disease, this is likely to drive coronary stent market. According to National Centre for bio-technology information western countries are majorly affected by coronary heart  diseases which accounts to death of around 1/3 of old aged people. According to American Heart Association statics on heart disease and stroke of 2016, around 15.5 million people in U.S.A were affected by coronary heart disease. Further, as per the National institute of health (NIH), United States, about 8.5 % of global population i.e. 617 million people were of age 65 and above in 2015.

North America accounted for the largest market share in terms of revenue due to planned reimbursement policies, high healthcare spending. However, Asia pacific is expected to high CAGR during the forecast period 2016-2023 due to positive effect of market factors in the region such as, rising prevalence of cardiac diseases, increasing adoption of advance technology in the region and low manufacturing costs in the region.

The global coronary stent market report covers segmentation analysis of type, mode of delivery, material and end user. The report further covers segmentation analysis of coronal stent type which includes Bare-Metal Stents, Drug-Eluting Stents, Bioabsorbable Stents. Drug eluting stent segment is expected to account dominance during the forecast period 2016-2023. Segmentation on the basis of mode of delivery the coronary stent market is sub-segmented into Balloon-Expandable Stents and Self-Expanding Stents. Balloon expandable stent sub-segment of mode of delivery is expected to dominate the market. Material segment of global coronary stent market is segmented into Metallic Stents and Other Stents. End user the market is segmented into Hospitals, Cardiac Centres and Ambulatory Surgical Centres.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Fortimedix B.V.
  • I.B.S. S.P.A
  • Medtronic Plc (U.S)
  • Stentys Sa (France)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology
 
2. Market Overview
2.1. Global Coronary Stent Market: Evolution & Transition
2.2. Market Definition And Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360 Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Market Share & Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Technological Advancements
3.1.2. Rising Incidence of Coronary Artery Disease And Subsequent Growth in the Number of Pci Procedures
3.1.3. Increasing Demand for Minimally Invasive Procedures
3.1.4. Rising Geriatric Population
3.2. Market Restraints
3.2.1. Availability of Alternative Treatment Methods for Coronary Artery Disease
3.2.2. Stringent Regulations for Product Approval
3.2.3. Product Failure And Product Recalls
3.3. Market Opportunities
3.3.1. Bioresorbable Vascular Scaffolds
3.3.2. Emerging Markets
3.4.  Market Challenges
3.4.1. Complications Associated With Implantation of Stents
3.4.2. Declining Costs of Stents
 
4. Market Segmentation
4.1. Global Coronary Stent Market By Type
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Balloon-Expandable Stents Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Key Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Self-Expanding Stents Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Key Players & Key Products
4.1.5.2.4. Key Conclusions
4.2. Global  Coronary Stent Market By Material
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Metallic Stents Market
4.2.5.1.1. Adoption Scenario & Market Determinants
4.2.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.3. Key Players & Key Products
4.2.5.1.4. Key Conclusions
4.2.5.2. Global Other Stents Market
4.2.5.2.1. Adoption Scenario & Market Determinants
4.2.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.3. Key Players & Key Products
4.2.5.2.4. Key Conclusions
4.3. Global Coronary Stent Market By End User
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Hospitals Market
4.3.5.1.1. Adoption Scenario & Market Determinants
4.3.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.3. Key Players & Key Products
4.3.5.1.4. Key Conclusions
4.3.5.2. Global Cardiac Centers Market
4.3.5.2.1. Adoption Scenario & Market Determinants
4.3.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.3. Key Players & Key Products
4.3.5.2.4. Key Conclusions
4.3.5.3. Global Ambulatory Surgical Centers Market
4.3.5.3.1. Adoption Scenario & Market Determinants
4.3.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.3. Key Players & Key Products
4.3.5.3.4. Key Conclusions
 
5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers & Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships
 
6. Global Coronary Stent Market By Region
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4.  Geographic Segmentation
6.4.1. North America
6.4.1.1. Industry Application Analysis
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023  ($ Million)
6.4.1.2.1.2. Key Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Key Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Application Analysis
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Key Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Key Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Key Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Rest of Europe
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Key Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Application Analysis
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Key Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Key Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Key Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Rest of Asia Pacific
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Key Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Application Analysis
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Key Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Key Players & Key Products
6.4.4.2.2.3. Key Conclusions
 
7. Company Profiles
7.1. Medtronic Plc (U.S)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Strategic Initiatives
7.1.4. Scot Analysis
7.1.5. Strategic Analysis
7.2. Abbott Laboratories (U.S).
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Strategic Initiatives
7.2.4. Scot Analysis
7.2.5. Strategic Analysis
7.3. Boston Scientific Corporation.(U.S)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Strategic Initiatives
7.3.4. Scot Analysis
7.3.5. Strategic Analysis
7.4. Biosensors International Group, Ltd (Singapore).
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Strategic Initiatives
7.4.4. Scot Analysis
7.4.5. Strategic Analysis
7.5. Biotronik Se & Co. Kg (Germany).
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Strategic Initiatives
7.5.4. Scot Analysis
7.5.5. Strategic Analysis
7.6.  B. Braun Melsungen Ag (Germany)
7.6.1. Overview
7.6.2. Strategic Initiatives
7.6.3. Scot Analysis
7.6.4. Strategic Analysis
7.7.  Terumo Corporation (Japan).
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Strategic Initiatives
7.7.4. Scot Analysis
7.7.5. Strategic Analysis
7.8. Stentys Sa (France)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Strategic Initiatives
7.8.4. Scot Analysis
7.8.5. Strategic Analysis
7.9. Microport Scientific Corporation (China)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Strategic Initiatives
7.9.4. Scot Analysis
7.9.5. Strategic Analysis
7.10. Meril Life Sciences Pvt. Ltd (India)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Strategic Initiatives
7.10.4. Scot Analysis
7.10.5. Strategic Analysis
7.11. Vascular Concepts Limited (India).
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Strategic Initiatives
7.11.4. Scot Analysis
7.11.5. Strategic Analysis
7.12. Translumina Gmbh (Germany)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Strategic Initiatives
7.12.4. Scot Analysis
7.12.5. Strategic Analysis
7.13. Fortimedix B.V.
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Strategic Initiatives
7.13.4. Scot Analysis
7.13.5. Strategic Analysis
7.14. I.B.S. S.P.A
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Strategic Initiatives
7.14.4. Scot Analysis
7.14.5. Strategic Analysis
7.15. Microport Scientific Corporation
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Strategic Initiatives
7.15.4. Scot Analysis
7.15.5. Strategic Analysis
 
List of Tables
1. Global Vascular Stent Market By Type 2014-2023 ($ Million)
2. Global Bare-Metal Stents By Geography 2014-2023 ($ Million)
3. Global Drug-Eluting Stents Market By Geography 2014-2023 ($ Million)
4. Global Bioabsorbable Stents Market By Geography 2014-2023 ($ Million)
5. Global Coronary Stent Market By Mode of Delivery2014-2023 ($ Million)
6. Global Balloon-Expandable Stents Market By Geography 2014-2023 ($ Million)
7. Global Self-Expanding Stents Market By Geography 2014-2023 ($ Million)
8. Global Coronary Stent Market By Material 2014-2023 ($ Million)
9. Global Metallic Stents Market By Geography 2014-2023 ($ Million)
10. Global Other Stents Market By Geography 2014-2023 ($ Million)
11. Global Coronary Stent Market By End User 2014-2023 ($ Million)
12. Global Hospitalsmarket By Geography 2014-2023 ($ Million)
13. Global Cardiac Centersmarket By Geography 2014-2023 ($ Million)
14. Global Ambulatory Surgical Centersmarket By Geography 2014-2023 ($ Million)
15. North America Coronary Stent Market 2014-2023 ($ Million)
16. Europe Coronary Stent Market 2014-2023 ($ Million)
17. Asia Pacific Coronary Stent Market 2014-2023 ($ Million)
18. Rest of the World Coronary Stent Market 2014-2023 ($ Million)
 
List of Figures
1. Global Vascular Stent Market By Type 2014-2023 ($ Million)
2. Global Bare-Metal Stents 2014-2023 ($ Million)
3. Global Drug-Eluting Stents Market 2014-2023 ($ Million)
4. Global Bioabsorbable Stents Market 2014-2023 ($ Million)
5. Global Coronary Stent Market By Mode of Delivery2014-2023 ($ Million)
6. Global Balloon-Expandable Stents Market 2014-2023 ($ Million)
7. Global Self-Expanding Stents Market 2014-2023 ($ Million)
8. Global Coronary Stent Market By Material 2014-2023 ($ Million)
9. Global Metallic Stents Market 2014-2023 ($ Million)
10. Global Other Stents Market 2014-2023 ($ Million)
11. Global Coronary Stent Market By End User 2014-2023 ($ Million)
12. Global Hospitalsmarket By Y 2014-2023 ($ Million)
13. Global Cardiac Centersmarket  2014-2023 ($ Million)
14. Global Ambulatory Surgical Centersmarket 2014-2023 ($ Million)
15. United States (U.S.) Coronary Stent Market 2014-2023 ($ Million)
16. Canada Coronary Stent Market 2014-2023 ($ Million)
17. United Kingdom (Uk) Coronary Stent Market 2014-2023 ($ Million)
18. France Coronary Stent Market 2014-2023 ($ Million)
19. Germany Coronary Stent Market 2014-2023 ($ Million)
20. Spain Coronary Stent Market 2014-2023 ($ Million)
21. Roe Coronary Stent Market 2014-2023 ($ Million)
22. India Coronary Stent Market 2014-2023 ($ Million)
23. China Coronary Stent Market 2014-2023 ($ Million)
24. Japan Coronary Stent Market 2014-2023 ($ Million)
25. Australia Coronary Stent Market 2014-2023 ($ Million)
26. Roapac Coronary Stent Market 2014-2023 ($ Million)
27. Latin America Coronary Stent Market 2014-2023 ($ Million)
28. Mena Coronary Stent Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories (U.S).
  • B. Braun Melsungen Ag (Germany)
  • Biosensors International Group, Ltd (Singapore).
  • Biotronik Se & Co. Kg (Germany).
  • Boston Scientific Corporation.(U.S)
  • Fortimedix B.V.
  • I.B.S. S.P.A
  • Medtronic Plc (U.S)
  • Meril Life Sciences Pvt. Ltd (India)
  • Microport Scientific Corporation
  • Microport Scientific Corporation (China)
  • Stentys Sa (France)
  • Terumo Corporation (Japan).
  • Translumina Gmbh (Germany)
  • Vascular Concepts Limited (India).
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll